The test is the first to be approved for the company's second-generation molecular detection system, but can also be run using the first-generation system alongside other existing assays.
The technology is identifying sources of foodborne pathogen outbreaks more quickly and precisely than older technology.
The organization has been scaling up its use of NGS and bioinformatics and a recent NARMS publication is the first of many that will incorporate sequencing data.
The US Food and Drug Administration tracked a recent multi-state Listeria outbreak using whole-genome sequencing.
The revenue spike was due to an increase in the number of Atlas molecular testing platforms placed with commercial customers.
The molecular diagnostics company said the number of Atlas instruments placed with customers under commercial agreements rose to 41 from 38 in Q4 2014.
The 3M Molecular Detection Assay 2 – Listeria monocytogenes is 30 percent faster than the first-generation test.
The fourth quarter revenue growth resulted from an increase in its Atlas instrument placements, as well as an increase in the commercial use of the instrument.
The partners will collaborate to develop and validate a high-throughput DNA microarray-based detection system to monitor foodborne bacteria and viruses.
NEW YORK (GenomeWeb) – New Zealand Medical and Scientific will distribute Invisible Sentinel's Veriflow assays in New Zealand under an agreement announced today.
The New York Times and ProPublica say that many physicians fail to disclose their financial ties when publishing in medical journals.
The Wall Street Journal reports Human Longevity's valuation has dropped by 80 percent.
Science reports that the US National Cancer Institute is cutting its operating budget by 5 percent.
In PLOS this week: similar variants seen in bullbogs, people with Robinow syndrome; ApoE genotypes in African-American, Puerto Rican populations; and more.